Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 289

1.

Reply letter: "We Never Speak About Sudden Unexpected Death in Parkinson's Disease".

Alves M, Caldeira D, Ferro JM, Ferreira JJ.

Eur J Neurol. 2020 Mar 16. doi: 10.1111/ene.14216. [Epub ahead of print]

PMID:
32176407
2.

Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson's Disease.

Alves M, Caldeira D, Rato ML, Duarte GS, Ferreira AN, Ferro J, Ferreira JJ.

J Parkinsons Dis. 2020;10(2):641-651. doi: 10.3233/JPD-191907.

PMID:
32116264
3.

Contingent negative variation: a biomarker of abnormal attention in Functional Movement Disorders.

Teodoro T, Koreki A, Meppelink AM, Little S, Nielsen G, Macerollo A, Ferreira JJ, Pareés I, Lang A, Edwards MJ.

Eur J Neurol. 2020 Feb 24. doi: 10.1111/ene.14189. [Epub ahead of print]

PMID:
32096289
4.

Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review.

Bouça-Machado R, Duarte GS, Patriarca M, Castro Caldas A, Alarcão J, Fernandes RM, Mestre TA, Matias R, Ferreira JJ.

Mov Disord Clin Pract. 2019 Dec 11;7(2):129-139. doi: 10.1002/mdc3.12874. eCollection 2020 Feb. Review.

PMID:
32071930
5.

Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.

Leitão R, Guerreiro C, Nunes RG, Gonçalves N, Galati G, Rosário M, Guedes LC, Ferreira JJ, Reimão S.

J Huntingtons Dis. 2020 Feb 12. doi: 10.3233/JHD-190388. [Epub ahead of print]

PMID:
32065802
6.

Motor, cognitive and mobility deficits in 1000 geriatric patients: protocol of a quantitative observational study before and after routine clinical geriatric treatment - the ComOn-study.

Geritz J, Maetzold S, Steffen M, Pilotto A, Corrà MF, Moscovich M, Rizzetti MC, Borroni B, Padovani A, Alpes A, Bang C, Barcellos I, Baron R, Bartsch T, Becktepe JS, Berg D, Bergeest LM, Bergmann P, Bouça-Machado R, Drey M, Elshehabi M, Farahmandi S, Ferreira JJ, Franke A, Friederich A, Geisler C, Hüllemann P, Gierthmühlen J, Granert O, Heinzel S, Heller MK, Hobert MA, Hofmann M, Jemlich B, Kerkmann L, Knüpfer S, Krause K, Kress M, Krupp S, Kudelka J, Kuhlenbäumer G, Kurth R, Leypoldt F, Maetzler C, Maia LF, Moewius A, Neumann P, Niemann K, Ortlieb CT, Paschen S, Pham MH, Puehler T, Radloff F, Riedel C, Rogalski M, Sablowsky S, Schanz EM, Schebesta L, Schicketmüller A, Studt S, Thieves M, Tönges L, Ullrich S, Urban PP, Vila-Chã N, Wiegard A, Warmerdam E, Warnecke T, Weiss M, Welzel J, Hansen C, Maetzler W.

BMC Geriatr. 2020 Feb 6;20(1):45. doi: 10.1186/s12877-020-1445-z.

7.

The risks of converting post-hoc findings into primary outcomes in subsequent trials.

Rodrigues FB, Ferreira JJ.

Ann Transl Med. 2019 Dec;7(Suppl 8):S337. doi: 10.21037/atm.2019.09.105. No abstract available.

8.

Inhaled levodopa for intermittent treatment of OFF episodes in patients with Parkinson's disease.

Simões RM, Castro Caldas A, Ferreira JJ.

Expert Rev Clin Pharmacol. 2020 Feb;13(2):85-101. doi: 10.1080/17512433.2020.1724535. Epub 2020 Feb 14. Review.

PMID:
32011195
9.

Progesterone and estrogen regulate NALCN expression in human myometrial smooth muscle cells.

Amazu C, Ma X, Henkes C, Ferreira JJ, Santi CM, England SK.

Am J Physiol Endocrinol Metab. 2020 Apr 1;318(4):E441-E452. doi: 10.1152/ajpendo.00320.2019. Epub 2020 Jan 14.

PMID:
31935111
10.

The "long and winding road" of the disease-modifying effects of levodopa has not ended yet.

Leal Rato M, Rascol O, Ferreira JJ.

Mov Disord. 2020 Mar;35(3):397-399. doi: 10.1002/mds.27961. Epub 2019 Dec 24. No abstract available.

PMID:
31872511
11.

Swimming is compromised in Parkinson's disease patients.

Neves MA, Bouça-Machado R, Guerreiro D, Caniça V, Pona-Ferreira F, Ferreira JJ.

Mov Disord. 2020 Feb;35(2):365-369. doi: 10.1002/mds.27918. Epub 2019 Dec 4.

PMID:
31799732
12.

Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis.

Caldeira D, Alves M, David C, Costa J, Ferreira JJ, Pinto FJ.

Prim Care Diabetes. 2019 Nov 30. pii: S1751-9918(19)30439-5. doi: 10.1016/j.pcd.2019.11.004. [Epub ahead of print] Review.

PMID:
31791903
13.

Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease.

Silva CM, Travessa AM, Bouça-Machado R, Caldeira D, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Dec;69:150-156. doi: 10.1016/j.parkreldis.2019.11.011. Epub 2019 Nov 13.

PMID:
31760307
14.

Levodopa response in later stages of Parkinson's disease: A case-control study.

Fabbri M, Coelho M, Abreu D, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Oct 29. pii: S1353-8020(19)30470-5. doi: 10.1016/j.parkreldis.2019.10.027. [Epub ahead of print] No abstract available.

PMID:
31722819
15.

Reply to letter: Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis.

Alves M, Caldeira D, Ferro JM, Ferreira JJ.

Eur J Neurol. 2020 Feb;27(2):e12. doi: 10.1111/ene.14125. Epub 2019 Nov 29. No abstract available.

PMID:
31710751
16.

Cardiovascular events reported in randomized controlled trials in restless legs syndrome.

Duarte GS, Alves M, Silva MA, Camara R, Caldeira D, Ferreira JJ.

Sleep Med. 2020 Jan;65:13-17. doi: 10.1016/j.sleep.2019.06.022. Epub 2019 Jul 6.

PMID:
31706187
17.

The association of influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series.

Caldeira D, Rodrigues B, David C, Costa J, Pinto FJ, Ferreira JJ.

Expert Rev Vaccines. 2019 Nov;18(11):1211-1217. doi: 10.1080/14760584.2019.1690459. Epub 2019 Dec 10.

PMID:
31693865
18.

Tapentadol Prevents Motor Impairments in a Mouse Model of Dyskinesia.

Vaz RL, Chapela D, Coelho JE, Lopes LV, Ferreira JJ, Afonso ND, Sousa S, Outeiro TF.

Neuroscience. 2020 Jan 1;424:58-71. doi: 10.1016/j.neuroscience.2019.08.046. Epub 2019 Nov 1.

PMID:
31682948
19.

Are genetic and idiopathic forms of Parkinson's disease the same disease?

Correia Guedes L, Mestre T, Outeiro TF, Ferreira JJ.

J Neurochem. 2020 Mar;152(5):515-522. doi: 10.1111/jnc.14902. Epub 2019 Dec 8. Review.

PMID:
31643079
20.

Recommendations and levels of evidence in the guidelines of the European Society of Cardiology: current scenario and time trends.

Caldeira D, Marques A, Almeida J, Rodrigues T, Alves M, David C, Gonçalves N, Costa J, Ferreira JJ, Pinto FJ.

Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):122-124. doi: 10.1093/ehjcvp/pvz060. No abstract available.

PMID:
31621843
21.

Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis.

Faustino PR, Duarte GS, Chendo I, Castro Caldas A, Reimão S, Fernandes RM, Vale J, Tinazzi M, Bhatia K, Ferreira JJ.

JAMA Neurol. 2019 Oct 14. doi: 10.1001/jamaneurol.2019.3446. [Epub ahead of print]

PMID:
31609378
22.

A critique of the fragility index.

Machado T, Duarte GS, Gonçalves N, Ferreira JJ, Costa J.

Lancet Oncol. 2019 Oct;20(10):e553. doi: 10.1016/S1470-2045(19)30581-9. Epub 2019 Sep 30. No abstract available.

PMID:
31578995
23.

Safety Profile of Opicapone in the Management of Parkinson's Disease.

Lees A, Ferreira JJ, Rocha JF, Rascol O, Poewe W, Gama H, Soares-da-Silva P.

J Parkinsons Dis. 2019;9(4):733-740. doi: 10.3233/JPD-191593.

PMID:
31498127
24.

Should the Energy Contribution of Commercial Thickeners Be Considered in the Nutrition Plan of Patients With Dysphagia?

Miranda D, Breda J, Cardoso R, Gonçalves N, Caldas AC, Ferreira JJ.

Nutr Clin Pract. 2019 Sep 5. doi: 10.1002/ncp.10408. [Epub ahead of print]

PMID:
31489690
25.

Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta-analysis.

Alves M, Caldeira D, Ferro JM, Ferreira JJ.

Eur J Neurol. 2020 Feb;27(2):288-296. doi: 10.1111/ene.14076. Epub 2019 Sep 20.

PMID:
31454134
26.

Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies.

Rodrigues BS, David C, Costa J, Ferreira JJ, Pinto FJ, Caldeira D.

Heart. 2020 Mar;106(5):350-357. doi: 10.1136/heartjnl-2019-315193. Epub 2019 Aug 23.

PMID:
31444266
27.

Huntington's Disease Clinical Trials Corner: June 2019.

Rodrigues FB, Ferreira JJ, Wild EJ.

J Huntingtons Dis. 2019;8(3):363-371. doi: 10.3233/JHD-199003.

28.

Electronic search strategies fail to identify randomized controlled trials (RCTs) in neurosurgery.

Gorayeb RP, Forjaz MJ, Ferreira AG, Duarte GNS, Machado T, Ferreira JJ.

Clin Neurol Neurosurg. 2019 Sep;184:105446. doi: 10.1016/j.clineuro.2019.105446. Epub 2019 Jul 14. Review.

PMID:
31377675
29.

Nocebo response in Parkinson's disease: A systematic review and meta-analysis.

Leal Rato M, Duarte GS, Ferreira AN, Alves M, Mainoli B, Teodoro T, Mestre TA, Costa J, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Aug;65:13-19. doi: 10.1016/j.parkreldis.2019.04.015. Epub 2019 Apr 20. Review.

PMID:
31103487
30.

Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?

Fabbri M, Zibetti M, Ferrero G, Accornero A, Guimaraes I, Rizzone MG, Romagnolo A, Ferreira JJ, Lopiano L.

Parkinsonism Relat Disord. 2019 Jul;64:242-248. doi: 10.1016/j.parkreldis.2019.04.018. Epub 2019 Apr 28.

PMID:
31060986
31.

MDS evidence-based review of treatments for essential tremor.

Ferreira JJ, Mestre TA, Lyons KE, Benito-León J, Tan EK, Abbruzzese G, Hallett M, Haubenberger D, Elble R, Deuschl G; MDS Task Force on Tremor and the MDS Evidence Based Medicine Committee.

Mov Disord. 2019 Jul;34(7):950-958. doi: 10.1002/mds.27700. Epub 2019 May 2. Review.

PMID:
31046186
32.

Corrigendum to "Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis" [Arch. Gerontol. Geriatr. 81 (March-April) (2019) 209-214].

Caldeira D, Nunes-Ferreira A, Rodrigues R, Vicente E, Pinto FJ, Ferreira JJ.

Arch Gerontol Geriatr. 2019 Jul - Aug;83:338. doi: 10.1016/j.archger.2019.04.008. Epub 2019 Apr 26. No abstract available.

PMID:
31036372
33.

A critique of the second consensus criteria for multiple system atrophy.

Stankovic I, Quinn N, Vignatelli L, Antonini A, Berg D, Coon E, Cortelli P, Fanciulli A, Ferreira JJ, Freeman R, Halliday G, Höglinger GU, Iodice V, Kaufmann H, Klockgether T, Kostic V, Krismer F, Lang A, Levin J, Low P, Mathias C, Meissner WG, Kaufmann LN, Palma JA, Panicker JN, Pellecchia MT, Sakakibara R, Schmahmann J, Scholz SW, Singer W, Stamelou M, Tolosa E, Tsuji S, Seppi K, Poewe W, Wenning GK; Movement Disorder Society Multiple System Atrophy Study Group.

Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29. No abstract available.

PMID:
31034671
34.

Proper or Improper Use of the Crossover Design in Clinical Trials in Chronic Sciatica?

Leal Rato M, Duarte GS, Ferreira JJ.

JAMA Neurol. 2019 Jun 1;76(6):731. doi: 10.1001/jamaneurol.2019.0870. No abstract available.

PMID:
31034000
35.

Dysphagia predicts poor outcome in late-stage Parkinson's disease.

Fabbri M, Coelho M, Abreu D, Guedes LC, Rosa MM, Godinho C, Cardoso R, Guimaraes I, Antonini A, Zibetti M, Lopiano L, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Jul;64:73-81. doi: 10.1016/j.parkreldis.2019.02.043. Epub 2019 Mar 2.

PMID:
30902528
36.

Morphine in acute coronary syndrome: systematic review and meta-analysis.

Duarte GS, Nunes-Ferreira A, Rodrigues FB, Pinto FJ, Ferreira JJ, Costa J, Caldeira D.

BMJ Open. 2019 Mar 15;9(3):e025232. doi: 10.1136/bmjopen-2018-025232.

37.

Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis.

Caldeira D, Alves D, Costa J, Ferreira JJ, Pinto FJ.

PLoS One. 2019 Feb 20;14(2):e0211228. doi: 10.1371/journal.pone.0211228. eCollection 2019.

38.

Integrating genetic and physical positions of the anthracnose resistance genes described in bean chromosomes Pv01 and Pv04.

Murube E, Campa A, Ferreira JJ.

PLoS One. 2019 Feb 14;14(2):e0212298. doi: 10.1371/journal.pone.0212298. eCollection 2019.

39.

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P.

Eur J Neurol. 2019 Jul;26(7):953-960. doi: 10.1111/ene.13914. Epub 2019 Mar 25.

40.

Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis.

Caldeira D, Nunes-Ferreira A, Rodrigues R, Vicente E, Pinto FJ, Ferreira JJ.

Arch Gerontol Geriatr. 2019 Mar - Apr;81:209-214. doi: 10.1016/j.archger.2018.12.013. Epub 2018 Dec 27. Erratum in: Arch Gerontol Geriatr. 2019 Jul - Aug;83:338.

PMID:
30612074
41.

Optogenetics: the new molecular approach to control functions of neural cells in epilepsy, depression and tumors of the central nervous system.

Camporeze B, Manica BA, Bonafé GA, Ferreira JJC, Diniz AL, de Oliveira CTP, Mathias Junior LR, de Aguiar PHP, Ortega MM.

Am J Cancer Res. 2018 Oct 1;8(10):1900-1918. eCollection 2018. Review.

42.

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the Movement Disorder Society Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

43.
44.

Genetic diversity assessed by genotyping by sequencing (GBS) and for phenological traits in blueberry cultivars.

Campa A, Ferreira JJ.

PLoS One. 2018 Oct 23;13(10):e0206361. doi: 10.1371/journal.pone.0206361. eCollection 2018.

45.

Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.

Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L.

Eur J Neurol. 2019 Mar;26(3):490-496. doi: 10.1111/ene.13844. Epub 2018 Nov 18.

46.

Oxytocin can regulate myometrial smooth muscle excitability by inhibiting the Na+ -activated K+ channel, Slo2.1.

Ferreira JJ, Butler A, Stewart R, Gonzalez-Cota AL, Lybaert P, Amazu C, Reinl EL, Wakle-Prabagaran M, Salkoff L, England SK, Santi CM.

J Physiol. 2019 Jan;597(1):137-149. doi: 10.1113/JP276806. Epub 2018 Nov 22.

47.

Adjunctive Therapies in Parkinson's Disease: How to Choose the Best Treatment Strategy Approach.

Fabbri M, Rosa MM, Ferreira JJ.

Drugs Aging. 2018 Dec;35(12):1041-1054. doi: 10.1007/s40266-018-0599-2. Review.

PMID:
30318555
48.

Strong nocebo effect in amyotrophic lateral sclerosis trials might mask conclusions.

Rato ML, Duarte GS, Mestre T, de Carvalho M, Ferreira JJ.

Lancet Neurol. 2018 Oct;17(10):842. doi: 10.1016/S1474-4422(18)30310-7. Epub 2018 Sep 18. No abstract available.

PMID:
30264722
49.

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.

Fabbri M, Ferreira JJ, Lees A, Stocchi F, Poewe W, Tolosa E, Rascol O.

Mov Disord. 2018 Oct;33(10):1528-1539. doi: 10.1002/mds.27475. Epub 2018 Sep 27. Review.

PMID:
30264443
50.

The placebo response in Parkinson's disease and other movement disorders.

Mestre TA, Ferreira JJ.

Mov Disord. 2018 Aug;33(8):1193-1194. doi: 10.1002/mds.27476. No abstract available.

PMID:
30230628

Supplemental Content

Loading ...
Support Center